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Abstract 
 
Background: Cardiovascular diseases are among the most important causes of morbidity and mortality in the 
world. One of the important risk factors of cardiovascular disease is hyperlipidemia especially high levels of 
serum cholesterol. Due to the importance of hypercholesterolemia, being a serious condition, various treatments 
are used to control it, regardless of the cause, most of treatments, focused on reducing the level of serum lipids. 
This study aims to determine various view points for hypercholesterolemia in Iranian traditional medicine. 
 
Methods: We used several Iranian traditional medicine resources and literatures; then based on these texts; a 
pilot study was designed to assess their effects in 10 patients with high plasma cholesterol. The sign and symp-
toms in main digestive organs (Stomach and liver) were also evaluated. 
 
Results: Some patients showed hepatic temperament but all patients had gastric temperament.  
 
Conclusion: With reference to Iranian traditional medical texts and literatures, the organs involved in the pro-
cess of digestion, particularly the stomach and the liver play the most important role. Yet the proper function of 
stomach as the first step involved in the digestion chain should be emphasized. 
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Introduction 
 
Lipids are body components which play important 
roles in energy storage and in the structure of the cell 
membranes, hormones and secondary mediators. 
Plasma lipid concentration depends on the balance 
between production, consumption and deposition of 
lipids.
1 The hyperlipidemia theory is based on the 
biochemical changes in the blood, i.e. disturbed lipid 
metabolism and as a consequence of increased con-
centration of lipids in the blood circulation.
2 Rising 
plasma lipid levels can lead to disorders such as ath-
erosclerosis.
3-6 Atherosclerosis is a progressive disor-
der causally related to multiple cardiovascular diseas-
es like coronary artery disease (CAD).
7-11 CAD is a 
leading cause of mortality, morbidity, and disability 
in the world.
12,13 The high prevalence and morbidity 
associated with CAD in Iran is one of the most press-
ing health problems.
14 One of the important risk fac-
tors which have been identified in connection with 
ischemic heart disease is the high level of serum cho-
lesterol.
15-21 According to the American Heart Asso-
ciation report, 102.2 million Americans age 20 and 
older have total blood cholesterol levels of 200 milli-
grams per deciliter or higher.
22 
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The important point in atherosclerosis disorder is to 
modify the level of lipids; because improved lipid levels 
to prevent atherosclerosis is the foundation.
23 There are 
different ways to treat hypercholesterolemia, such as 
diet therapy and drug therapy. Several studies indicated 
diet therapy not to be very promising
24 and drug therapy 
may have different complications.
25 Now, day-by-day 
several different synthetic drugs of better efficacy are 
being introduced. But apart from being effective, most 
of them induce adverse side effects.
25 For instance; 
statins, among the most commonly prescribed of medi-
cations which are used for the treatment of hypercholes-
terolemia and for the prevention of coronary heart dis-
ease
26 are related with various musculoskeletal side ef-
fects.
27  Therefore, these potential agents could not be 
used for a prolonged period of time but hyperlipidemia 
requires long term treatment.
2 So it is important to 
choose lipid lowering methods and medications that do 
not adversely affect their efficacy profile, or reinforce 
their potential negative side effects. Therefore, search 
for safe and effective cholesterol lowering methods was 
the main motivating factor behind this study. Today the 
world is moving towards integrating traditional and 
complementary medicine
28 with the mainstream medi-
cine to increase efficacy and to decrease side effects and 
costs.
29 One of the oldest and richest school of tradition-
al medicine is the Iranian traditional medicine.
30 Thus in 
this article, we presented hypercholesterolemia from the 
viewpoint of Iranian traditional medicine as has been 
known unani medicine. To understand this perspective, 
it is necessary to explain some principles.  
The Iranian traditional medicine system makes ef-
fort to propose the best possible ways by which a per-
son can lead an optimum healthy life with least ill-
ness. The Iranian traditional medicine framework is 
based on some principals. One of the important prin-
ciples is "Umore Tabiya". Umore Tabiya includes 
different parts: Arkan (Rokn), Amzaj (Mizaj, Temper-
ament),  Akhlat (Khelt, humour),  Aza (Ozv),  Arvah 
(Rooh), Qova (Qova) and Afal (Fel), respectively.
31-33 
"Mizaj" (temperament) is a quality which is a con-
sequence of mutual interaction of the four contradic-
tory primary qualities (Hot, Cold, Wet, Dry) residing 
within the elements. These elements are so meticu-
lously intermixed with each other that they lie in a 
very intimate relationship to one another. Their oppo-
site powers intermittently conquer and are conquered 
until a state of balance is reached which is uniform 
throughout the whole. This result was given the name 
of temperament (Mizaj).
34-36   In other words, Mizaj 
means the dominant quality of the composite object. 
Mizaj is one of the most important canons of Ira-
nian traditional medicine system. It has an important 
function in maintaining the ideal healthy state of an 
individual. Vulnerability of its altered temperament 
which is called dystemperament (Sui' e Mizaj) leads 
to several different types of diseases.
37 
"Humor" which is called in the Iranian traditional 
medicine texts as "Khelt" is a wet and fluid substance 
which foodstuffs in the first stage of permutation chang-
es to it. Normally  there are  four  humors  in  the human 
body: "Phlegm or Balgham, Blood or Dam, Yellow bile 
or Safra and Black bile or Sauda". Each of the humors 
was related with pairs of qualities including cold and 
wet, hot and wet, hot and dry, and cold and dry, respec-
tively.
38-41 In addition, each of humor in the characteris-
tics is similar to one of the four elements: water, air, fire 
and earth, respectively.
42-44 
 
Lipids and Humors  
In the Iranian traditional medicine texts, there is 
no concept of hypercholesterolemia as such; but in 
many cases has been described it as a disorder. As far 
as the presence of fat (Lipids) is concerned in blood, 
Ibn Sina (Avicenna) an ancient Iranian traditional 
physician
45-48 has reported its existence in blood, pro-
duced from "Dosoomat Al-Dam".
2,49 " Dosoomat" 
means "fatty, oily"
50 and "Dam" means "blood".
51 
Dosoomat of blood or the oily substance could be 
the lipids but as the biochemical analysis of blood was 
not available and they could not describe it as per 
modern parameters.
2 According to the fundamentals of 
Iranian traditional medicine, the blood circulating in 
the vessels is a combination of four humors.
52 There-
fore, the clues of blood lipids should be sought be-
tween the humors. Thus to clarify this issue, it is nec-
essary to describe the production path of the humors. 
 
The Digestion Pathway: Humor Production 
Based on available evidences and the detailed de-
scriptions of the Iranian traditional medicine resources, 
ingested food undergoes various stages of digestion 
before reaching the tissues.
53,54  Ibn-Sina (Avicenna) 
and most of the Hakims (The wise master physicians 
of Iranian traditional medicine), are all of the opinion 
that digestion is a continuous process taking place from 
the mouth to the tissue that can be divided into four 
sequential stages
10 including the gastric digestion 
stage, the hepatic digestion stage, the vascular diges-
tion stage and the tissue digestion stage. 
Each stage of the digestion is composed of specific 
processing of the food material that must be carried on Body humors and hypercholesterolemia 
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until it becomes suitable for used by the body. In each 
digestion process, the following actions take place 
(Figure 1):
55  
1. In the gastric digestion, some of the traits and 
characteristics of food material changes and appro-
priate absorbable material named "Chylous" is ab-
sorbed via the mesenteric vessels to the liver for 
further digestion. 
2. In the hepatic digestion stage, the chylous is 
changed in to the "Chymous" that is composed of 
four humors (blood, phlegm, yellow and black 
bile), which will circulate in the vessels. 
3. In the vascular digestion stage, the food state gets 
closer to the tissue state . 
4. During the tissue digestion stage, food becomes 
quite similar to the end organ tissue. 
As it was expressed, the humors are the final prod-
ucts of the hepatic digestion and in order for the hu-
mors, to be of good quality two conditions must be met 
including (i) Normal liver function for proper digestion 
and (ii) The (Gastric chylous), which is used by the 
liver for the production of humors that must have an 
appropriate composition. The second condition would 
not be present unless the stomach function properly 
and the ingested food is of good quality. 
 
Abnormal Humour Production Results in Lipid Disorders 
According the  book "The Qanon of Medicine" (by 
Avicenna), the foundation of Iranian traditional medi-
cine system  was based on the balancing humors in 
the human body.
56,57 Their imbalance caused several 
different diseases whereas restoration of the balance 
led to health.
56,57 Based on the Al-Qanun fi al-Tibb, 
the blood and what flows within the vessels (such as 
plasma lipids) are the product of the second diges-
tion.
52 Thus, high plasma lipid conditions may be due 
to dysfunction of one or two of the previous digestion 
stages (Hepatic and gastric digestion stages). 
As it was expressed previously, the continuity be-
tween the stages of digestion and even the organs in-
volved is such that any disorder in one of them would 
bring about a disorder in other organs and stages. Ab-
normal vascular content may be a consequence of 
hepatic maldigestion. Also the hepatic maldigestion, 
itself may be a consequence of gastric maldigestion. 
In other word, abnormal gastric chylous results in 
abnormal hepatic chymous and abnormal hepatic 
chymous results in abnormal humors (Figure 2). It 
should also be noted that even a healthy liver does not 
have the ability to convert abnormal chylous into 
normal chymous and then normal humors.
58  
The most important point is that due to the close 
relationship between different organs that contribute 
to the digestive chain, the impairment in each of the 
stages of digestion will ultimately cause production of 
abnormal humor. This abnormal humor does not have 
the quality to become the desired end product. In later 
stages of digestion, the abnormal humor affects the 
function of organs consuming it and furthermore may 
gradually cause dysfunction of the next responsible 
organ in the digestion chain.
59  
 
Clinical Support 
Based on the above hypothesis, to find the respon-
sible organ causing hypercholesterolemia and to pro-
vide scientific basis for deeply studying the relation 
between body humors and hypercholesterolemia, a 
pilot study was designed to assess 10 patients with 
high plasma cholesterol. The sign and symptoms of 
the dystemperament (Sui' a Mizaj) of the main diges-
tive organs (Stomach and liver) were obtained. Symp-
toms which according to them the medical history 
was taken, were derived from the traditional diagnos-
tic and treatment books, like The Qanon of Medicine 
of Ibn Sina (Avicenna),
60 the Kholasatol Hekmah,
61 
the Moalejate Aghili,
62 the Exir-e-Azam of Hakim 
Azam Khan,
63 the Sharhe Asbaab-o-Alaamaat of Sa-
marghandi,
64 the Zakhirah -E- Kharazm Shahi,
65 Al- 
 
Fig. 1: Four stages of digestion. 
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Tasrif Le man ajeza an Talif
66 and the Asbab va 
Alayem.
67 Subsequently the data was tabulated and 
arranged so that full conclusions could be gained. 
 
 
Results 
 
Our study indicated that only some of the patients had 
hepatic dystemperament (Sui' a Mizaj) and surpris-
ingly all of the patients had gastric dystemperament. 
The significant difference between the results of gas-
tric and hepatic dystemperament in our patients,   
suggests that the responsible organ involved in hyper-
cholesterolemia is the stomach. Furthermore; the he-
patic dysfunction, if not considered to be a conse-
quence of gastric failure, will be the second responsi-
ble organ. Results of this study provide information 
for using Iranian traditional medicine in clinic and 
developing Iranian traditional medicine. 
 
 
Discussion 
 
With reference to Iranian traditional medical texts, one 
Good quality of food intaked  Bad quality of food intaked 
Normal gastric digestion  Maldigestion 
Normal gastric chylous  Abnormal gastric chylous 
Normal hepatic digestion  Abnormal hepatic digestion 
Normal blood composition  Abnormal blood composition 
(including hypercholesterolemia) 
Normal hepatic chymous  Abnormal hepatic chymous 
 
 
Fig. 2: Different pathways of causing abnormal blood composition (including hypercholesterolemia). Body humors and hypercholesterolemia 
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can reach the basic point that organs involved in the 
process of digestion, particularly the stomach and the 
liver play the most important role in determining the 
blood composition. However, the proper function of 
stomach as the first step involved in the digestion chain 
should be emphasized. If the gastric digestion is im-
paired, the rest of the organs involved in digestion like 
the liver, blood vessels and tissues cannot be provided 
with the necessary qualified raw material (chylous) and 
therefore may suffer dysfunction, thus causing abnor-
mal product formation such as abnormal humors and 
blood composition.  
It can be concluded that the first and best action 
in the treatment of hypercholesterolemia is to treat 
the stomach dystemperament (Stomach Sui' a Mizaj) 
and if then the disorder persists, the dystemperament 
of the liver should be considered. Further clinical 
study is recommended to investigate this issue. 
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